| Patent Number |
Title Of Patent |
Date Issued |
| 8211914 |
Inhibitors of diacylglycerol acyltransferase |
July 3, 2012 |
| Provided herein are amides containing at least a four ring structure, which are inhibitors of diacylglycerol acyltransferase and are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome. |
| 8211884 |
Diacylglycerol acyltransferase inhibitors |
July 3, 2012 |
| Provided herein are compounds of the formula (I): ##STR00001## as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment |
| 8153644 |
Diacylglycerol acyltransferase inhibitors |
April 10, 2012 |
| Provided herein are compounds of the formula (I): ##STR00001## as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment |
| 8124766 |
Inhibitors of diacylglycerol acyltransferase |
February 28, 2012 |
| Provided herein are compounds of the formula (I): ##STR00001## as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment |
| 8115011 |
Diacylglycerol acyltransferase inhibitors |
February 14, 2012 |
| Provided herein are compounds of the formula (I): ##STR00001## as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment |
| 8058299 |
Diacylglycerol acyltransferase inhibitors |
November 15, 2011 |
| Provided herein are compounds of the formula (I): ##STR00001## as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment |
| 8039495 |
Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators |
October 18, 2011 |
| Provided herein are compounds of the formula (I): ##STR00001## as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment |
| 7947728 |
Indole and indazole analogs as glycogen synthase activators |
May 24, 2011 |
| Provided herein are compounds of the formula (I): ##STR00001## as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment |
| 7939569 |
Aniline analogs as glycogen synthase activators |
May 10, 2011 |
| Provided herein are compounds of the formula (I): ##STR00001## as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment |
| 7714126 |
Diacylglycerol acyltransferase inhibitors |
May 11, 2010 |
| Provided herein are compounds of the formula (I): ##STR00001## as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment |
| 7317125 |
Diacylglycerol acyltransferase inhibitors |
January 8, 2008 |
| Provided herein are compounds of the formula (I): ##STR00001## as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment |
| 7067529 |
Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
June 27, 2006 |
| Compounds of formula I are provided ##STR00001## as well as pharmaceutically acceptable salts and esters thereof, wherein the substituents are as disclosed in the specification. The compounds have utility for the treatment of type 2 diabetes mellitus. |
| 7037924 |
Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
May 2, 2006 |
| Compounds of formula (I) are provided, ##STR00001## wherein R.sup.1 and R.sup.2 are as designated in the specification. The compounds have utility for the treatment of type 2 diabetes mellitus. |
| 6316593 |
Synthesis of VIP analog |
November 13, 2001 |
| This invention relates to a novel process for the synthesis of vasoactive intestinal peptide analog Ac(1-31)-NH2 from four protected peptide fragments. |
| 6080837 |
Synthesis of VIP analog |
June 27, 2000 |
| This invention relates to a novel process for the synthesis of vasoactive intestinal peptide analog Ac(1-31)--NH.sub.2 from four protected peptide fragments. |
| 5677419 |
Cyclic vasoactive peptide analogs |
October 14, 1997 |
| Analogs of porcine Vasoactive Intestinal Peptide are disclosed. The analogs have been cyclized by the covalent attachment, via an amide bond, of the side-chain carboxy terminus of one amino acid in the peptide chain to the side-chain amino terminus of another amino acid in the peptide ch |
